Idera Pharma (IDRA) Reports In-Line Q2 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq futures rise as AI stocks rebound ahead of key earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Oil slips from 5-month high as Trump's Russia sanctions waiver may bring more supplies
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Goldman warns high investor conviction could amplify volatility as sentiment shift
Tweet
Share
E-mailGet Alerts IDRA Hot Sheet
Join SI Premium – FREE
Idera Pharma (NASDAQ: IDRA) reported Q2 EPS of ($0.11), in-line with the analyst estimate of ($0.11).
For earnings history and earnings-related data on Idera Pharma (IDRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HDFC Bank Limited (HDB) Tops Q3 EPS by 1c
- Dynex Capital stock slips 2% on third quarter earnings miss
- UBS sees attractive risk/reward in three European medtech into Q3 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
